CD79B Gene Agammaglobulinemia type 6 Autosomal Recessive Genetic Test
Overview
CD79B gene agammaglobulinemia type 6 is a rare genetic disorder that is inherited in an autosomal recessive manner. It is caused by mutations in the CD79B gene, which is involved in the development and function of B cells in the immune system.
Test Details
The CD79B Gene Agammaglobulinemia type 6 autosomal recessive genetic test is conducted using NGS (Next Generation Sequencing) technology. This type of genetic test allows for the simultaneous analysis of multiple genes, making it a powerful tool for identifying genetic mutations.
Test Components
- Test Name: CD79B Gene Agammaglobulinemia type 6 autosomal recessive Genetic Test
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Hematology
- Doctor: Hematologist
- Test Department: Genetics
Pre Test Information
Before undergoing the CD79B Gene Agammaglobulinemia type 6 autosomal recessive NGS Genetic DNA Test, it is important to provide the clinical history of the patient. A genetic counseling session may also be conducted to draw a pedigree chart of family members affected with CD79B Gene Agammaglobulinemia type 6 autosomal recessive NGS Genetic DNA Test gene CD79B.
Benefits of the Test
- Confirms diagnosis in individuals suspected to have CD79B Gene Agammaglobulinemia type 6
- Carrier testing for individuals with a family history of the disorder
- Provides information about the specific genetic mutation present
- Useful for genetic counseling and family planning
Important Note
Genetic testing should be performed and interpreted by a qualified healthcare professional or genetic counselor. They can provide guidance on the implications of the test results and help individuals make informed decisions about their health.
Test Name | CD79B Gene Agammaglobulinemia type 6 autosomal recessive Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Hematology |
Doctor | Hematologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CD79B Gene Agammaglobulinemia type 6, autosomal recessive NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CD79B Gene Agammaglobulinemia type 6, autosomal recessive NGS Genetic DNA Test gene CD79B |
Test Details |
CD79B gene agammaglobulinemia type 6 is a rare genetic disorder that is inherited in an autosomal recessive manner. It is caused by mutations in the CD79B gene, which is involved in the development and function of B cells in the immune system. NGS (Next Generation Sequencing) genetic testing is a type of genetic test that can be used to identify mutations in the CD79B gene. This test involves sequencing the entire gene to detect any changes or mutations that may be present. NGS technology allows for the simultaneous analysis of multiple genes, making it a powerful tool for identifying genetic mutations. The NGS genetic test for CD79B gene agammaglobulinemia type 6 can help confirm a diagnosis in individuals suspected to have the condition. It can also be used for carrier testing in individuals with a family history of the disorder. Additionally, NGS testing can provide information about the specific genetic mutation present, which can be useful for genetic counseling and family planning. It is important to note that genetic testing should be performed and interpreted by a qualified healthcare professional or genetic counselor. They can provide guidance on the implications of the test results and help individuals make informed decisions about their health. |